|
|
Article: Studies Find Aspirin Resistance in up to 27% of Aspirin Users With Highest Incidence Among Women, Elderly and Low Dose Patients; Link to Plavix Resistance Also Revealed; Research Shows VerifyNow(TM) Aspirin Test Can Be Used to Predict Patients at Risk and Identify Lowest Effective Aspirin Dose.
- Article from:
- PR Newswire
- Article date:
- March 6, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ORLANDO, Fla., March 6 /PRNewswire/ -- While aspirin remains a crucial and cost-effective therapy for the prevention and management of cardiovascular diseases, research suggests that a significant percentage of the 25 million Americans on a chronic aspirin regimen are "aspirin resistant," or do not achieve sufficient antiplatelet effects from aspirin. The VerifyNow Aspirin Test (Ultegra) is emerging as an important tool to aid clinicians in quantifying this risk and taking appropriate action.
Previous studies have shown that aspirin resistance is associated with triple the risk of heart attack, stroke and death. Once patients are tested and identified as ...